文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

COVID-19 疫苗接种状态与 ICU 患者结局的关联

Association Between Vaccination Status and Outcomes in Patients Admitted to the ICU With COVID-19.
PubMed 文献 · Crit Care Med · 2023-05-16
一句话结论在因 COVID-19 入住 ICU 的患者中,接种疫苗与未接种者的院内死亡率相似,但接种者机械通气时间和 ICU 住院时间更短,加强针可能提高生存率。

该回顾性队列研究纳入加拿大阿尔伯塔省 2021 年 1 月至 2022 年 7 月因 COVID-19 入住 ICU 的 3293 例患者,其中完全接种 743 例(22.6%,54.6% 接种加强针)、部分接种 166 例(5.0%)、未接种 2384 例(72.4%)。倾向性匹配分析显示,未接种组与完全接种组院内死亡率相似(31.8% vs 34.0%,调整 OR 1.25;95%CI 0.97-1.61),但未接种组机械通气时间(7.6 vs 4.7 天;p<0.001)和 ICU 住院时间(6.6 vs 5.2 天;p<0.001)更长。在接种疫苗的患者中,至少接种 1 剂加强针者院内死亡率更低(25.5% vs 40.9%;调整 OR 0.50;95%CI 0.36-0.68),机械通气时间也更短(3.8 vs 5.6 天;p=0.025)。

要点

  • 在倾向性匹配分析中,未接种组与完全接种组院内死亡率相似(31.8% vs 34.0%,调整 OR 1.25;95%CI 0.97-1.61)。
  • 未接种组机械通气时间(7.6 vs 4.7 天;p<0.001)和 ICU 住院时间(6.6 vs 5.2 天;p<0.001)均长于完全接种组。
  • 在接种疫苗的患者中,至少接种 1 剂加强针者院内死亡率更低(25.5% vs 40.9%;调整 OR 0.50;95%CI 0.36-0.68)。
  • 未接种组更可能需要有创机械通气(78.4% vs 68.2%)、血管加压药(71.1% vs 66.6%)和体外膜氧合(2.1% vs 0.5%)。
  • 在 COVID-19 疫苗广泛可及后,因 COVID-19 入住 ICU 的患者中近四分之一为疫苗突破性感染病例。

适用人群与场景

  • 2021 年 1 月至 2022 年 7 月期间入住加拿大阿尔伯塔省 ICU、经 SARS-CoV-2 聚合酶链反应检测确诊 COVID-19 的患者。

研究设计与关键结果

  • 研究类型为回顾性队列,纳入 3293 例患者:完全接种 743 例(22.6%,其中 54.6% 接种加强针)、部分接种 166 例(5.0%)、未接种 2384 例(72.4%)。
  • 未接种组 vs 完全接种组:需要有创机械通气 78.4% vs 68.2%,使用血管加压药 71.1% vs 66.6%,使用体外膜氧合 2.1% vs 0.5%。
  • 倾向性匹配分析中,未接种组 vs 完全接种组院内死亡率相似(31.8% vs 34.0%,调整 OR 1.25;95%CI 0.97-1.61)。
  • 未接种组 vs 完全接种组中位机械通气时间 7.6 vs 4.7 天(p<0.001),中位 ICU 住院时间 6.6 vs 5.2 天(p<0.001)。
  • 在接种疫苗的患者中,至少接种 1 剂加强针者 vs 未接种加强针者院内死亡率 25.5% vs 40.9%(调整 OR 0.50;95%CI 0.36-0.68),机械通气时间 3.8 vs 5.6 天(p=0.025)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,COVID-19 疫苗接种与 ICU 资源利用减少相关,加强针接种可能提高 COVID-19 相关危重症的生存率。
  • 在危重症发生后,接种与未接种患者的死亡风险仍很高且相似,不应因患者已接种疫苗而低估其病情严重程度。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Although COVID-19 vaccines can reduce the need for intensive care unit admission in COVID-19, their effect on outcomes in critical illness remains unclear. We evaluated outcomes in vaccinated patients admitted to the ICU with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the association between vaccination and booster status on clinical outcomes.

DESIGN: Retrospective cohort.

SETTING AND PATIENTS: All patients were admitted to an ICU between January 2021 (after vaccination was available) and July 2022 with a diagnosis of COVID-19 based on a SARS-CoV-2 polymerase chain reaction test in Alberta, Canada.

INTERVENTIONS: None.

MEASUREMENT: The propensity-matched primary outcome of all-cause in-hospital mortality was compared between vaccinated and unvaccinated patients, and vaccinated patients were stratified by booster dosing. Secondary outcomes were mechanical ventilation (MV) duration ICU length of stay (LOS).

MAIN RESULTS: The study included 3,293 patients: 743 (22.6%) were fully vaccinated (54.6% with booster), 166 (5.0%) were partially vaccinated, and 2,384 (72.4%) were unvaccinated. Unvaccinated patients were more likely to require invasive MV (78.4% vs 68.2%), vasopressor use (71.1% vs 66.6%), and extracorporeal membrane oxygenation (2.1% vs 0.5%). In a propensity-matched analysis, in-hospital mortality was similar (31.8% vs 34.0%, adjusted odds ratio [OR], 1.25; 95% CI, 0.97-1.61), but median duration MV (7.6 vs 4.7 d; p < 0.001) and ICU LOS (6.6 vs 5.2 d; p < 0.001) were longer in unvaccinated compared to fully vaccinated patients. Among vaccinated patients, greater than or equal to 1 booster had lower in-hospital mortality (25.5% vs 40.9%; adjusted OR, 0.50; 95% CI, 0.0.36-0.68) and duration of MV (3.8 vs 5.6 d; p = 0.025).

CONCLUSIONS: Nearly one in four patients admitted to the ICU with COVID-19 after widespread COVID-19 vaccine availability represented a vaccine-breakthrough case. Mortality risk remains substantial in vaccinated patients and similar between vaccinated and unvaccinated patients after the onset of critical illness. However, COVID-19 vaccination is associated with reduced ICU resource utilization and booster dosing may increase survivability from COVID-19-related critical illness.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. van Diepen S, McAlister FA, Chu LM, et al. Association Between Vaccination Status and Outcomes in Patients Admitted to the ICU With COVID-19. Crit Care Med. 2023. PMID: 37192450. doi:10.1097/CCM.0000000000005928

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。